US Stock MarketDetailed Quotes
ORKA Oruka Therapeutics
- 24.890
- -1.110-4.27%
Close Sep 13 16:00 ET
- 24.890
- 0.0000.00%
Post 20:01 ET
731.73MMarket Cap-65500P/E (TTM)
27.065High24.180Low136.53KVolume26.840Open26.000Pre Close3.45MTurnover0.61%Turnover RatioLossP/E (Static)29.40MShares33.00052wk High3.21P/B555.57MFloat Cap10.06852wk Low--Dividend TTM22.32MShs Float40838092.445Historical High--Div YieldTTM11.10%Amplitude10.068Historical Low25.282Avg Price1Lot Size
Oruka Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | |
|---|---|
| Total revenue | 0 |
| Operating revenue | --0 |
| Cost of revenue | |
| Gross profit | |
| Operating expense | 21.49M |
| Selling and administrative expenses | --2.82M |
| -General and administrative expense | --2.82M |
| Research and development costs | --18.67M |
| Operating profit | -21.49M |
| Net non-operating interest income expense | -750K |
| Non-operating interest expense | --750K |
| Other net income (expense) | |
| Income before tax | -22.24M |
| Income tax | |
| Net income | -22.24M |
| Net income continuous Operations | ---22.24M |
| Minority interest income | |
| Net income attributable to the parent company | -22.24M |
| Preferred stock dividends | |
| Other preferred stock dividends | |
| Net income attributable to common stockholders | -22.24M |
| Basic earnings per share | -0.7566 |
| Diluted earnings per share | -0.7566 |
| Dividend per share | |
| Currency Unit | USD |
| Accounting Standards | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data